Marcia Stenn Professor of Gynecologic Oncology, Northwestern University Medical School
Obstetrics & Gynecology
Dr. John R. Lurain, MD
|
|
Give Review
John Lurain works in the field of Obstetrics & Gynecology. He attended University of North Carolina at Chapel Hill School of Medicine. University of North Carolina at Chapel Hill School of Medicine is a top medical university. University of North Carolina at Chapel Hill School of Medicine is ranked 22 in research and 2 in primary care medicine He received 3 awards: "Meaningful Use Stage 1 Certification", "Top MD" and "Fellow (FACOG)". John R. Lurain is also a published doctor. He has 98 paper published. The most recent paper is: Perceptions of cisplatin-related toxicity among ovarian cancer patients and gynecologic oncologists. John R. Lurain accepts Medicare payments and is listed with Medicare.gov.
Publications
- Postmolar chorioCarcinoma: An independent risk factor for chemotherapy resistance in low-risk gestational trophoblastic neoplasia.
- Uterine Sarcoma, Version 1.2016.
- Characterization of the Influence of Semen-Derived Enhancer of Virus Infection (SEVI) on the Interaction of HIV-1 with Female Reproductive Tract Tissues.
- Defining the Interaction of HIV-1 with the Mucosal Barriers of the Female Reproductive Tract.
- Evaluation of Outcomes in Patients With Carcinoma of the Cervix Treated With Concurrent Radiation and Cisplatin Versus Cisplatin/5-FU Compared With Radiation Alone.
- The combination of intravenous bevacizumab and metronomic oral cyclophosphamide is an effective regimen for platinum-resistant recurrent ovarian Cancer.
- Dosimetry and toxicity outcomes in postoperative high-dose-rate intracavitary brachytherapy for endometrial Carcinoma.
- Establishment of Human Patient-Derived Endometrial Cancer Xenografts in NOD scid Gamma Mice for the Study of Invasion and Metastasis.
- Newer diagnostic approaches to the evaluation of gynecologic malignancies.
- Familial ovarian Cancer.
- Colposcopic evaluation of DES-exposed progeny at two large medical centers: the squamous neoplasia problem.
- Management of abnormal Papanicolaou smears in pregnancy.
- Intrauterine device use and endometrial Cancer risk.
- Childhood ovarian Cancers. New advances in treatment.
- Hsp70 and Hsc70 are preferentially expressed in differentiated epithelial cells in normal Human endometrium and ectocervix.
- Invasive mole.
- Medroxyprogesterone acetate (Depo-Provera) vs. hydroxyprogesterone caproate (Delalutin) in women with metastatic endometrial adenoCarcinoma.
- Ovarian tumor antigens.
- The significance of positive peritoneal cytology in endometrial Cancer.
- Endometrial adenoCarcinoma associated with drug-induced hyperprolactinemia.
- Mechanisms of growth in hydatidiform moles.
- ChorioCarcinoma associated with term gestation.
- Gestational trophoblastic tumors.
- Neoplasms of endometrial stroma: histopathologic and flow cytometric Analysis with clinical correlation.
- Pregnancy outcome subsequent to consecutive hydatidiform moles.
- Chylous ascites: a sequel of Pelvic radiation therapy.
- ChorioCarcinoma associated with ectopic pregnancy.
- Dual-parameter flow cytometric Analysis coupling the measurements of forward-angle light scatter and DNA content of archival ovarian carcinomas of low malignant potent...
- Cytoplasmic localization of endothelial constitutive nitric oxide synthase in endometrial Carcinomas.
- Fatal gestational chorioCarcinoma. Clinicopathologic study of patients treated at a trophoblastic disease center.
- A two-step approach to the treatment of invasive vulvar Cancer in pregnancy.
- Metastatic gestational trophoblastic disease: secondary chemotherapy.
- The study and treatment of gestational trophoblastic diseases at the Brewer Trophoblastic Disease Center, 1962-1979.
- Uterine arteriovenous malformations: primary treatment with therapeutic embolization.
- Natural history of hydatidiform mole after primary evacuation.
- The value of Cervical cytology in HIV-infected women.
- The effect of reimbursement policies on the management of Medicare patients with refractory ovarian Cancer.
- Hexamethylmelamine in ovarian Cancer after failure of cisplatin-based multiple-agent chemotherapy.
- Gestational trophoblastic disease. The effect of duration of disease and hCG titer on response to therapy.
- Repeat gestational trophoblastic disease.
- Fatal gestational trophoblastic disease: an Analysis of treatment failures.
- Laparoscopic descending colostomy in three patients with cervical Carcinoma.
- Case-control study of endogenous steroid hormones and endometrial Cancer.
- Laparoscopically assisted vaginal hysterectomy in a university hospital: report of 82 cases and comparison with abdominal and vaginal hysterectomy.
- Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors.
- Markedly elevated maternal serum alpha-fetoprotein associated with a normal fetus and chorioCarcinoma of the placenta.
- Hydatidiform mole: clinicopathologic associations with the development of postevacuation trophoblastic disease.
- Classification and staging of gestational trophoblastic tumors.
- Placental site trophoblastic tumor associated with immature ovarian teratoma.
- Ovarian Carcinoma metastatic to the choroid of the eye.
- Castleman disease presenting as a Pelvic mass.
- Evaluating the total costs of chemotherapy-induced toxicity: results from a pilot study with ovarian Cancer patients.
- Study and treatment of gestational trophoblastic diseases at the John I. Brewer Trophoblastic Disease Center, 1962-1990.
- Mutations of the estrogen receptor in endometrial Carcinoma: evidence of an association with high tumor grade.
- Cost analysis of second-line therapies for platinum-refractory ovarian Cancer: reimbursement dilemmas for Medicare patients.
- Unanticipated pregnancy with intrauterine growth retardation after radiation-induced ovarian failure. A case report.
- Microinvasive cervix Cancer.
- Oral contraceptive use and risk of gestational trophoblastic tumors.
- Gestational trophoblastic disease: treatment results at the Brewer Trophoblastic Disease Center.
- Leiomyoma causing massive ascites, right pleural effusion and respiratory distress. A case report.
- Tumor size in endometrial Cancer.
- Rare gynecologic malignancies.
- Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy.
- Major basic protein as a marker of malignant potential in trophoblastic neoplasia.
- The role of contraception in the development of postmolar gestational trophoblastic tumor.
- Gestational trophoblastic disease metastatic to the brain.
- Flow cytometric evaluation of early invasive cervical Cancer.
- Tumor size in endometrial Cancer: a prognostic factor for lymph node metastasis.
- Flow cytometric evaluation of epithelial ovarian Cancer.
- Causes of treatment failure in gestational trophoblastic disease.
- Management of twin pregnancies consisting of a complete hydatidiform mole and normal fetus.
- Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanc...
- Prognostic factors in gestational trophoblastic tumors: a proposed new scoring system based on multivariate Analysis.
- Prognostic significance of positive peritoneal cytology in clinical stage I adenoCarcinoma of the endometrium.
- High-risk metastatic gestational trophoblastic tumors. Current management.
- Whole-abdominal radiation in endometrial carcinoma: an Analysis of toxicity, patterns of recurrence, and survival.
- Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease.
- Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy.
- Ovarian Carcinoma initially presenting as metastatic axillary lymphadenopathy.
- Ectopic pregnancy causing hemothorax managed by thoracoscopy and actinomycin D.
- DNA flow cytometric Analysis of clinical stage I endometrial carcinomas with lymph node metastases.
- Prognostic factors associated with recurrence in clinical stage I adenoCarcinoma of the endometrium.
- Perceptions of cisplatin-related toxicity among ovarian Cancer patients and gynecologic oncologists.
- Endometrial adenoCarcinoma metastatic to the scalp: case report and literature review.
- Participation of the general gynecologist in surgical staging of endometrial Cancer: analysis of cost and perioperative outcomes.
- Protein kinase C alpha expression is inversely related to ER Status in endometrial carcinoma: possible role in AP-1-mediated proliferation of ER-negative endometrial c...
- Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving sys...
- Uterine Neoplasms. Clinical Practice Guidelines in Oncology.
- Cervical Cancer.
- Uterine Cancers.
- Uterine leiomyosarcoma metastatic to the sphenoid sinus: a case report and review of the literature.
- Should uterine tandem applicators ever be placed without ultrasound guidance? No: a brief report and review of the literature.
- The role of lymphadenectomy in surgical staging of endometrial Cancer.
- Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors.
- Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy.
- Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
- Placental site trophoblastic tumor: a review of 7 cases and their implications for prognosis and treatment.
Schools
University Of North Carolina Chapel Hill School Of Medicine
University PittsburghMagee Womens H
Roswell Park Canc Institute
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Colposcopy
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- Destruction or Excision of Vaginal Lesions
- View All
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Asymptomatic Post-Menopausal Status
- View All
Doctors Specialties
- Gynecologic Oncology
- Oncology
- Obstetrics
- Gynecology
Accepted Insurances
- Aetna
- American Republic
- Assurant Health
- Blue Cross Blue Shield
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Golden Rule
- Medicare Advantage PFFS
- HealthLink PPO
- Choice Care PPO
- Medical Mutual of Ohio
- Medicare MCR
- Medico
- MultiPlan PPO
- PHCS Network PPO
- NGS CoreSource
- Pipefitters
- Principal Life
- Tricare
- Choice Plus POS
- Options PPO
- United Healthcare
- Wisconsin Physicians Service
Awards
- Meaningful Use Stage 1 Certification
- Top MD
- Fellow (FACOG)
Education
-
University of Pittsburgh Medical Center -
University of North Carolina at Chapel Hill School of Medicine
Hospital
-
Northwestern Memorial Hospital -
Lurie Children's Hospital of Chicago
Drug Facts
| NPI NUMBER | 1902835853 | |
| NPPES Provider LastName | LURAIN | |
| NPPES Provider FirstName | JOHN | |
| NPPES Provider ZIPCode | 606114546 | |
| NPPES Provider State | IL | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 334.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 40.0 | |
| Percent Opioid Claims | 11.98 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1902835853 |
| Last Name Of The Provider | LURAIN |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
|
Dr. Edgardo L. Yordan Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Morteza Dini, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Freidoon Azizi Facog Facs, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carrie Smith, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ghodratollah Javaheri, MD |
|
|
Dr. Gloria L. Elam, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Nawar Hatoum, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. S D. Yamada, MD |
|
|
Dr. Brenda Darrell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allison E. Chen-McCracken, MD |
|
|
Dr. Amanda L. Dhuyvetter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kemi M. Doll, MD |